Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide

  • Catalog number
    M2E11-P
  • Price
    Please ask
  • Size
    100 ug
  • Stock availability
    Available
  • Category
    Recombinant Protein
  • Antibody type
    N/A
  • Antibody host
    N/A
  • Antibody conjugate
    N/A
  • Technical datasheet
    Contact Gentaur to request the datasheet or ask our specialists for more information.
  • Notes
    The Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.
  • Test
    You can block the antibody by the specific target amino acid sequence of peptide.
  • Properties
    blocking peptide
  • Description
    Isotype or positive controls by peptides, antibodies and deactivated samples. Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
  • Gene target
    Influenza   virus   H5N1   matrix   protein   hybrid  
  • Short name
    Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide
  • Technique
    blocking peptide, Blocking, Control, peptide, blocking peptides, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. controls, peptides
  • Species
    N/A, Influenza, Viruses
  • Alternative name
    Influenza A virus (H5N1) matrix protein 2 hybrid sequence reference/inhibiting short protein sequence
  • Alternative technique
    control, peptides, controls
  • Tissue
    control
  • Virus
    influenza
MeSH Data
  • Name
  • Concept
    Scope note: A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
  • Tree numbers
    • E05.393.760.700
  • Qualifiers
    ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data
Similar products
Filters
Contact
Chat with gentaur.com employee